NANTAHALA CAPITAL MANAGEMENT, LLC sold 0.0% of their position (41.00 shares) of EVOKE PHARMA INC on the open market
Open‑market sale worth $179.87 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/30/2025ACC: 0001104659-25-007682
10% Owner
Since Nov 2024
-41.00
Net shares
Net seller
$179.87
Total sold
1
Open market trades
0B · 1S
1
Total transactions
41.00 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−41.00
Price / share
$4.39
Trade value
$179.87
% of position
0.0%
1/28/2025
148.19K→148.15K
Total
Net shares
−41.00
Net value
-$179.87
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/28/2025 | S · Sale | −41.00 | $4.39 | $179.87 | 0.0% | 148.19K | 148.15K |
| Total | −41.00 | -$179.87 | ||||||
Derivative Transactions0
No derivative transactions reported